Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-18 Sale | 2021-11-19 7:39 pm | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer | 15,000 | $20.02 | $300,300 | 335,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-05 Equity Swap | 2024-04-08 4:14 pm | N/A N/A | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer | 121,647 | $0 | 0 (Direct) | View |
| 2024-04-05 Disposition | 2024-04-08 4:14 pm | N/A N/A | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer | 3,426,846 | $0 | 0 (Direct) | View |
| 2024-01-16 Tax Withholding | 2024-01-18 6:01 pm | N/A N/A | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J CHIEF EXECUTIVE OFFICER | 13,032 | $1.34 | 211,822 (Direct) | View |
| 2023-11-06 Disposition | 2023-11-08 6:09 pm | N/A 2025-04-21 | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer | 2,449,846 | $0 | 2,449,846 (Direct) | View |
| 2023-11-06 Option Award | 2023-11-08 6:09 pm | N/A 2025-04-21 | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer | 2,449,846 | $0 | 2,449,846 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-19 4:18 pm | 2023-06-18 2033-05-18 | Surrozen Inc. | SRZN | WOODHOUSE DAVID J Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 5:09 pm | N/A 2033-03-01 | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer | 1,008,800 | $0 | 1,106,454 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 5:51 pm | 2023-06-07 2032-06-07 | Surrozen Inc. | SRZN | WOODHOUSE DAVID J Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-04 4:06 pm | N/A 2032-03-02 | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2021-12-29 Exercise | 2021-12-30 5:09 pm | N/A N/A | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer | 12,987 | $7.7 | 242,500 (Direct) | View |
| 2021-12-29 Exercise | 2021-12-30 5:09 pm | N/A N/A | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer | 4,667 | $8.14 | 242,500 (Direct) | View |
| 2021-12-29 Exercise | 2021-12-30 5:09 pm | N/A 2027-01-19 | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer | 17,654 | $0 | 242,500 (Direct) | View |
| 2021-11-18 Exercise | 2021-11-19 7:39 pm | N/A N/A | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer | 15,000 | $7.54 | 335,000 (Direct) | View |
| 2021-11-18 Exercise | 2021-11-19 7:39 pm | N/A 2025-04-21 | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer | 15,000 | $0 | 335,000 (Direct) | View |
Ownership | 2021-08-16 7:52 pm | N/A N/A | Surrozen Inc. | SRZN | WOODHOUSE DAVID J Director | 0 | $0 | 35,129 (Direct) | View |
| 2021-03-17 Option Award | 2021-03-18 8:23 pm | N/A 2031-03-16 | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J Chief Executive Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2020-02-04 Option Award | 2020-02-06 8:02 pm | N/A 2030-02-03 | NGM BIOPHARMACEUTICALS INC | NGM | WOODHOUSE DAVID J CEO and acting CFO | 400,000 | $0 | 400,000 (Direct) | View |